Prevalence of Candiduria and Characterisation of Candida Species in Urinary Tract Infections from a Tertiary Care Hospital
Authors/Creators
- 1. Assistant Professor, Department of Microbiology, VIMS, Ballari
- 2. Professor, Department of Microbiology, VIMS, Ballari
- 3. Tutor, Department of Microbiology, VIMS, Ballari
- 4. Assistant Professor, Department of Microbiology, Viswabharathi Medical College, Kurnool
Description
Introduction: Candida species are the most prevalent human fungal diseases, according to reports. In recent decades, the incidence of urinary tract infections (UTIs) caused by Candida microorganisms has grown. The purpose of this study was to determine the Candida species responsible for UTIs in tertiary care hospitals. Materials and Methods: Candida species were detected separately using the germ tube test, colony staining on CHROMagar medium, intracellular beta-glucosidase enzyme activity, and glucose absorption pattern in 2868 urine samples acquired from patients with suspected UTI. Results: Out of 2868 urine samples, Candida species were isolated in 87 samples. In our study 40.2%, 32.2%, 16.1%, 10.3% and 1.2% of the isolates were identified as C. albicans, C. tropicalis C. glabrata, C. krusei and, C. Parapsilosis respectively. Patients between the ages of 21 and 40 were related with the largest number of Candida cases, while women were associated with the highest number of Candida cases. Conclusion: C. albicans has been identified as the most frequent fungus responsible for urinary tract infections.
Abstract (English)
Introduction: Candida species are the most prevalent human fungal diseases, according to reports. In recent decades, the incidence of urinary tract infections (UTIs) caused by Candida microorganisms has grown. The purpose of this study was to determine the Candida species responsible for UTIs in tertiary care hospitals. Materials and Methods: Candida species were detected separately using the germ tube test, colony staining on CHROMagar medium, intracellular beta-glucosidase enzyme activity, and glucose absorption pattern in 2868 urine samples acquired from patients with suspected UTI. Results: Out of 2868 urine samples, Candida species were isolated in 87 samples. In our study 40.2%, 32.2%, 16.1%, 10.3% and 1.2% of the isolates were identified as C. albicans, C. tropicalis C. glabrata, C. krusei and, C. Parapsilosis respectively. Patients between the ages of 21 and 40 were related with the largest number of Candida cases, while women were associated with the highest number of Candida cases. Conclusion: C. albicans has been identified as the most frequent fungus responsible for urinary tract infections.
Files
IJPCR,Vol15,Issue3,Article69.pdf
Files
(346.5 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:28deecc2268e222e2fec4be6435f3816
|
346.5 kB | Preview Download |
Additional details
Dates
- Accepted
-
2023-03-04
Software
- Repository URL
- https://impactfactor.org/PDF/IJPCR/15/IJPCR,Vol15,Issue3,Article69.pdf
- Development Status
- Active
References
- 1. Behzadi P, Behzadi E, Ranjbar R. Urinary tract infections and Candida albicans. Cent European J Urol. 2015; 68(1): 96–101. 2. Bongomin F, Gago S, Oladele Rand DW. Denning Global and Multi-National Prevalence of Fungal Diseases— Estimate Precision. J. Fungi. 2017; 3(4): 57-62 3. Fisher JF, Sobel JD, Kauffman CA, Newman CA. Candida urinary tract infections: treatment. Clin Infect Dis. 2011; 52: S457—66. 4. Rivett AG, perry JA, Cohen J. Urinary candidiasis, a Prospective study in hospitalized patient. Urol Ress. 1986; 14:153-161.5. Odds FC, Davidson A. Room temperature use of CHRO Magar canidida. Diagn Microbil and infect Dis. 2002; 58:147-150. 6. Kauffman C. A., Vazquez J. A., Sobel J. D., Gallis H. A., McKinsey D. S., Karchmer A. & Mosher A. Prospective multicenter surveillance study of funguria in hospitalized patients. Clinical Infectious Diseases, 2000; 30(1): 14-18. 7. Gubbins, P. O., Piscitelli, S. C., & Danziger, L. H. Candidal urinary tract infections: a comprehensive review of their diagnosis and management. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1993; 13(2): 110-127. 8. Gaschet F., & Lacour C. Métropolisation et ségrégation (No. hal-00154463). 2008. 9. Pasligh J., Radecke C., Fleischhacker M., & Ruhnke M. Comparison of phenotypic methods for the identification of Candida dubliniensis. Journal of Microbiology, Immunology and Infection, 2010;43(2): 147-154. 10. Morales DK, Hogan DA. Candida albicans Interactions with Bacteria in the Context of Human Health and Disease. PLOS Pathogens. 2010; 6: e1000886.1. 11. Malani AN, Kauffman CA. Candida urinary tract infections: treatment options. Expert Rev Anti Infect Ther. 2007; 5: 277-284. 12. Wagenlehner F, Wullt B, Ballarini S, Zingg D, Naber KG. Social and economic burden of recurrent urinary tract infections and quality of life: a patient web-based study (GESPRIT). Expert Rev Pharmacoecon Outcomes Res. 2018; 18: 107-117. 13. Aubron C, Suzuki S, Glassford NJ, Garcia-Alvarez M, Howden BP, Bellomo R. The epidemiology of bacteriuria and candiduria in critically ill patients. Epidemiol Infect. 2015; 143: 653-662. 14. Behzadi P, Behzadi E, Ranjbar R. Urinary tract infections and Candida albicans. Cent European J Urol. 2015; 68: 96-101. 15. Ding CH. Wahab AA, Muttaqillah NAS, Tzar MN. Prevalence of albicans and non-albicans candiduria in a Malaysian medical centre. J Pak Med Assoc. 2014; 64: 1375-1379. 16. Paul N., Mathai E., Abraham O., Michael J. S., & Mathai D. Factors associated with candiduria and related mortality. Journal of Infection, 2007; 55(5): 450-455. 17. Sobel JD, Fisher JF, Kauffman CA, Newman CA. Candida urinary tract infections- epidemiology. Clin Infect Dis. 2011;52 Suppl 6: S433-36. 18. Nayman S. A., Özguneş I., Ertem O. T., Erben N., Doyuk E. K., Tözun M., & Usluer G. Evaluation of risk factors in patients with candiduria. Mikrobiyoloji bulteni, 2011; 45(2), 318-324.